We are delighted to share that the ATTC Network, co-ordinated by the CGT Catapult has received funding from the NIHR. This funding will allow continuation and enhancement of advanced therapy clinical trial initiatives. Here is the full story:
ct.catapult.org.uk/news/17-9m-for…

Don’t miss this upcoming webinar hosted by the ATTC network on the 24 January 2024 at 1600 ‘Evaluation of the patient referral pathways for gene therapy and CAR-T in the UK’. Register here event.on24.com/wcc/r/4441182/…

In order to remain a life-sciences ‘superpower’ the UK needs to act now.
The ‘Advanced Therapies Adoption Challenge in the United Kingdom’ report provides key recommendations to support action. theattcnetwork.co.uk/network/attcs-…

#CellandGeneTherapy #AdvancedTherapies

Doing nothing is not an option in the field of Advanced Therapies. This report describes how the UK can retain its lead in the field. theattcnetwork.co.uk/network/attcs-… #CellandGeneTherapy #AdvancedTherapies

In Oct influential, knowledgeable and experienced minds met
RoySocMed in London to discuss barriers and develop solutions to the UK Advanced Therapies Adoption Challenge Read the report theattcnetwork.co.uk/network/attcs-…

In order to remain a life-sciences ‘superpower’ the UK needs to act now.
The ‘Advanced Therapies Adoption Challenge in the United Kingdom’ report provides key recommendations to support action. theattcnetwork.co.uk/network/attcs-…

The future of access for patients to life changing advanced therapies lies in the hands of policy-makers and, in order to remain a life-sciences ‘superpower’, the UK needs to act now. bit.ly/46LxN5l
#CellandGeneTherapy #AdvancedTherapies

ATMP Engage: ensuring patients are at the heart of ATMP delivery and research - register below for this webinar next Wed 8/12/23 hosted by the ATTC network.

event.on24.com/wcc/r/4374097/…

We have concluded a joint, successful project with the DMD Hub (Newcastle University) and the Cell and Gene Therapy Catapult, which has resulted in a publication that analyses the gene therapy patient referral pathways in the UK.
gbr01.safelinks.protection.outlook.com/?url=https%3A%…

Excited to be attending the 25th Communiqué awards with our clients @alderhey Cell and Gene Therapy Catapult Gilead Sciences. Good luck to all the finalists! Communiqué #cxhealth

Read all about the survey results led by our partner Autolus. The analysis looks at and evaluates the current landscape for electronic cell orchestration platforms.
theattcnetwork.co.uk/uncategorized/…

Future best practice recommendations coming soon for CAR-T patient referral pathways
ct.catapult.org.uk/news/new-colla…

Health Secretary Michael Matheson MSP has opened a new laboratory for cutting-edge work into potentially life-saving gene therapies in Edinburgh BioQuarter.

The innovative work led Cell and Gene Therapy Catapult will help ensure our healthcare systems are prepared for the future.

*New Publication* from our University of Manchester iMATCH team 🐝
Meta-analysis informed machine learning: Supporting cytokine storm detection during CAR-T cell Therapy 👉 bitly.ws/G5dA

NEWS: SRPT today shared a program update related to SRP-9001. Read our press release:
bit.ly/432xwKt

Our partners Cytiva and NHS Blood+Transplant have produced a document comparing liquid nitrogen and liquid nitrogen free controlled-rate freezing for the cryopreservation of MSCs.
theattcnetwork.co.uk/news/cryoprese…

Thousands of patients with sickle cell and thalassaemia, like Stephanie and Dean, can access a new gene test which helps to reduce the risk of painful side-effects of treatment.

Find out about this cutting edge genotyping in collaboration with NHS Blood+Transplant. england.nhs.uk/2023/05/world-…

Please share/complete this survey aimed at raising awareness of ATMPs lnkd.in/gHZcDx38